- The new campus combines research and development, manufacturing and training with the latest state-of-the-art facilities
- Brings innovation to the next level of integration with healthcare professionals
- It is expected to reach industrial scale production level with production value over 10 billion renminbi (about $1.38 billion) in three to five years
SINGAPORE, November 13, 2022 /PRNewswire/ — The Genesis MedTech Group (Genesis MedTech or Group) has officially unveiled its state-of-the-art medtech campus (Campus) in Wuxi, China. This is the first major R&D and manufacturing facility of its kind in Chinaextends over 135,333 m² and has completed its first development phase with an innovation center (Innovation Center) and two R&D and production centers (R&D and Manufacturing Center).
The Innovation Center provides an open educational platform to encourage deeper engagement and interaction between Genesis MedTech and healthcare professionals. It offers healthcare professionals access to clinical training on the latest medtech innovations, covering multiple disease areas such as: B. minimally invasive surgery, vascular procedures and structural heart disease.
The training facilities within the Innovation Center provide the highest level of education and hands-on experience, recreating real-world clinical situations to enable healthcare professionals to understand and become familiar with state-of-the-art medical devices.
The campus also houses the R&D and manufacturing center, which…
